RSV maternal vaccine (unadjuvanted)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RSV maternal vaccine (unadjuvanted), covering 2023-04-07 to 2024-02-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers [Phase 3]